Ingalls & Snyder LLC’s Cigna CI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $327K | Sell |
1,185
-10
| -0.8% | -$2.83K | 0.01% | 365 |
|
|
2026
Q1 | $319K | Hold |
1,195
| – | – | 0.01% | 361 |
|
|
2025
Q4 | $329K | Hold |
1,195
| – | – | 0.01% | 355 |
|
|
2025
Q3 | $344K | Sell |
1,195
-4
| -0.3% | -$1.18K | 0.01% | 354 |
|
|
2025
Q2 | $396K | Sell |
1,199
-9
| -0.7% | -$2.9K | 0.01% | 317 |
|
|
2025
Q1 | $397K | Buy |
1,208
+9
| +0.8% | +$2.71K | 0.01% | 325 |
|
|
2024
Q4 | $331K | Sell |
1,199
-75
| -6% | -$23.9K | 0.01% | 344 |
|
|
2024
Q3 | $441K | Hold |
1,274
| – | – | 0.02% | 316 |
|
|
2024
Q2 | $421K | Hold |
1,274
| – | – | 0.02% | 308 |
|
|
2024
Q1 | $463K | Sell |
1,274
-47
| -4% | -$15.5K | 0.02% | 300 |
|
|
2023
Q4 | $396K | Hold |
1,321
| – | – | 0.02% | 309 |
|
|
2023
Q3 | $378K | Sell |
1,321
-121
| -8% | -$34.5K | 0.02% | 311 |
|
|
2023
Q2 | $405K | Hold |
1,442
| – | – | 0.02% | 314 |
|
|
2023
Q1 | $368K | Hold |
1,442
| – | – | 0.02% | 314 |
|
|
2022
Q4 | $478K | Hold |
1,442
| – | – | 0.03% | 284 |
|
|
2022
Q3 | $400K | Hold |
1,442
| – | – | 0.02% | 296 |
|
|
2022
Q2 | $380K | Buy |
1,442
+94
| +7% | +$24.2K | 0.02% | 315 |
|
|
2022
Q1 | $323K | Hold |
1,348
| – | – | 0.01% | 358 |
|
|
2021
Q4 | $310K | Buy |
1,348
+54
| +4% | +$11.5K | 0.01% | 376 |
|
|
2021
Q3 | $259K | Hold |
1,294
| – | – | 0.01% | 396 |
|
|
2021
Q2 | $307K | Sell |
1,294
-151
| -10% | -$37.7K | 0.01% | 384 |
|
|
2021
Q1 | $349K | Hold |
1,445
| – | – | 0.02% | 340 |
|
|
2020
Q4 | $301K | Hold |
1,445
| – | – | 0.01% | 345 |
|
|
2020
Q3 | $245K | Hold |
1,445
| – | – | 0.02% | 324 |
|
|
2020
Q2 | $271K | Hold |
1,445
| – | – | 0.02% | 327 |
|
|
2020
Q1 | $256K | Hold |
1,445
| – | – | 0.02% | 343 |
|
|
2019
Q4 | $295K | Sell |
1,445
-28
| -2% | -$5.13K | 0.02% | 329 |
|
|
2019
Q3 | $224K | Hold |
1,473
| – | – | 0.01% | 387 |
|
|
2019
Q2 | $232K | Sell |
1,473
-121
| -8% | -$19K | 0.01% | 384 |
|
|
2019
Q1 | $256K | Hold |
1,594
| – | – | 0.01% | 366 |
|
|
2018
Q4 | $303K | Buy |
1,594
+620
| +64% | +$129K | 0.02% | 331 |
|
|
2018
Q3 | $203K | Buy |
+974
| New | +$181K | 0.01% | 418 |
|
Other funds holding CI
Ingalls & Snyder LLC's CI Position: Q2 2026 in Review
Ingalls & Snyder LLC reduced its Cigna (CI) stake by 0.84% in Q2 2026, selling an estimated $2.83K and leaving 1,185 shares worth $327K. The position accounts for 0.01% of the portfolio, ranked #365.
Ingalls & Snyder LLC first reported a position in CI in Q3 2018 and has held it in 32 quarters since. The position peaked at $478K in Q4 2022. 1,699 funds tracked by Wall St. Rank hold CI as of Q2 2026.
- Ingalls & Snyder LLC held 1,185 shares of Cigna worth $327K as of Q2 2026.
- Ingalls & Snyder LLC sold 10 Cigna shares in Q2 2026, an estimated $2.83K.
- Cigna made up 0.01% of Ingalls & Snyder LLC's portfolio in Q2 2026, its #365 holding.
- Ingalls & Snyder LLC first reported a position in Cigna in Q3 2018 and has held it in 32 quarters since.
- Ingalls & Snyder LLC's Cigna position peaked at $478K in Q4 2022.
- 1,699 funds tracked by Wall St. Rank held Cigna as of Q2 2026.
Based on Ingalls & Snyder LLC's 13F filing for Q2 2026, filed 14 Aug 2026.